Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
XERIS PHARMACEUTICALS INC (0001346302)
Standardized SEC financial data for XERIS PHARMACEUTICALS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001346302 · Pharmaceutical Preparations.
Gross margin
55.1%
Operating margin
-414.5%
Net margin
-452.2%
Revenue growth (YoY)
1138.8%
Return on equity
-270.0%
ROIC
-79.3%
Free cash flow
-$80.9M
Debt / equity
2.58×
Ratios for fiscal year 2020, standardized from SEC filings.